Katelynn's Report

Input CIK:

Show Other Options & Instructions

Owned(%):
Shares Outstanding(‱):
Transaction Code:

Instructions

Month Back: Display transaction record of previous n months.

Owned(%): Transaction shares relative to shares owned.

Shares Outstanding(‱): Transaction shares relative to shares outstanding.

Check Insider Trading (Reporter) for more details.

BAKER BROS. ADVISORS LP 1263508 Data last updated 2024-05-14 07:02:16 -0500 US CDT

Latest Holdings

Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.

3M	6M	1Y	2Y	MAX

Non-derivative Transactions CSV download

Tips: type "code_s" to show transactions with code "S".

Filing Date	Transaction Date	Operation Date	Original Filing	Reporter	Relation	Opr	Amount^a	%(Owned)^b	‱(SO)^c	Avg Prc^d	Account	Type	Full Name	Code	Remain	Shares Outstanding (Million)^e
2023-05-24	2023-05-22	2023-05-22 to 2023-05-24	4	Baker Bros. Advisors Lp	DIRECTOR, 10% OWNER	acq	88830.0	2.46	5.46	24.16	See Footnotes F4	Common Stock	ACADIA PHARMACEUTICALS INC	code_M,P code M P	3610443.0	162.63 (ACAD)
2023-05-24	2023-05-22	2023-05-22 to 2023-05-24	4	Baker Bros. Advisors Lp	DIRECTOR, 10% OWNER	acq	832692.0	2.12	51.2	25.2	See Footnotes F5	Common Stock	ACADIA PHARMACEUTICALS INC	code_M,P code M P	39317673.0	162.63 (ACAD)
2023-05-24	2023-05-22		4	Baker Bros. Advisors Lp	DIRECTOR, 10% OWNER	holding	205752.0	0	12.65	0.0	Direct	Common Stock	ACADIA PHARMACEUTICALS INC	code_ NA		162.63 (ACAD)
2023-06-02	2023-05-31	2023-05-31	4	Baker Bros. Advisors Lp	DIRECTOR, 10% OWNER	acq	2044.0	0.12	0.11	0.0	See Footnotes F3	Common Stock	SEAGEN INC.	code_A code A	1731202.0	187.5 (SGEN)
2023-06-02	2023-05-31	2023-05-31	4	Baker Bros. Advisors Lp	DIRECTOR, 10% OWNER	acq	2044.0	0.0	0.11	0.0	See Footnotes F4	Common Stock	SEAGEN INC.	code_A code A	42977301.0	187.5 (SGEN)
2023-06-02	2023-05-31		4	Baker Bros. Advisors Lp	DIRECTOR, 10% OWNER	holding	46557.0	0	2.48	0.0	Direct	Common Stock	SEAGEN INC.	code_ NA		187.5 (SGEN)
2023-06-05	2023-06-01		4	Baker Bros. Advisors Lp	DIRECTOR, 10% OWNER	holding	205752.0	0	12.65	0.0	Direct	Common Stock	ACADIA PHARMACEUTICALS INC	code_ NA		162.63 (ACAD)
2023-06-05	2023-06-01	2023-06-01	4	Baker Bros. Advisors Lp	DIRECTOR, 10% OWNER	acq	26608.0	0.07	1.64	0.0	See Footnotes F3	Common Stock	ACADIA PHARMACEUTICALS INC	code_A code A	39330977.0	162.63 (ACAD)
2023-06-08	2023-06-06	2023-06-06	4	Baker Bros. Advisors Lp	DIRECTOR	acq	17492.0	0.64	5.0	0.0	See Footnotes F3	Class A Common Shares	KINIKSA PHARMACEUTICALS, LTD.	code_A code A	2719343.0	34.97 (KNSA)
2023-06-08	2023-06-06		4	Baker Bros. Advisors Lp	DIRECTOR	holding	29680.0	0	8.49	0.0	Direct	Class A Common Shares	KINIKSA PHARMACEUTICALS, LTD.	code_ NA		34.97 (KNSA)
2023-06-16	2023-06-14		4	Baker Bros. Advisors Lp	DIRECTOR, 10% OWNER	holding	559963.0	0	25.1	0.0	Direct	Common Stock	INCYTE CORP	code_ NA		223.09 (INCY)
2023-06-16	2023-06-14	2023-06-14	4	Baker Bros. Advisors Lp	DIRECTOR, 10% OWNER	acq	5010.0	0.01	0.22	0.0	See Footnotes F4	Common Stock	INCYTE CORP	code_A code A	33445860.0	223.09 (INCY)
2023-06-16	2023-06-14		4	Baker Bros. Advisors Lp	DIRECTOR, 10% OWNER	holding	33410.0	0	1.5	0.0	See Footnotes F3	Common Stock	INCYTE CORP	code_ NA		223.09 (INCY)
2023-07-05	2023-06-30		4	Baker Bros. Advisors Lp	DIRECTOR, 10% OWNER	holding	559963.0	0	25.1	0.0	Direct	Common Stock	INCYTE CORP	code_ NA		223.09 (INCY)
2023-07-05	2023-06-30	2023-06-30	4	Baker Bros. Advisors Lp	DIRECTOR, 10% OWNER	acq	1024.0	0.0	0.05	0.0	See Footnotes F4	Common Stock	INCYTE CORP	code_A code A	33446372.0	223.09 (INCY)
2023-07-05	2023-06-30		4	Baker Bros. Advisors Lp	DIRECTOR, 10% OWNER	holding	33410.0	0	1.5	0.0	See Footnotes F3	Common Stock	INCYTE CORP	code_ NA		223.09 (INCY)
2023-07-05	2023-06-30	2023-06-30	4	Baker Bros. Advisors Lp	DIRECTOR	acq	1108.0	0.04	0.38	0.0	See Footnotes F1	Common Stock	IGM BIOSCIENCES, INC.	code_A code A	2896414.0	29.51 (IGMS)
2023-08-17	2023-08-15	2023-08-15 to 2023-08-17	4	Baker Bros. Advisors Lp	DIRECTOR, 10% OWNER	acq	174084.0	35.23	39.55	0.64	See Footnotes F4	Common Stock	NEOLEUKIN THERAPEUTICS, INC.	code_P code P	494133.0	44.02 (NLTX)
2023-08-17	2023-08-15	2023-08-15 to 2023-08-17	4	Baker Bros. Advisors Lp	DIRECTOR, 10% OWNER	acq	2111258.0	37.61	479.6	0.64	See Footnotes F5	Common Stock	NEOLEUKIN THERAPEUTICS, INC.	code_P code P	5612949.0	44.02 (NLTX)
2023-08-17	2023-08-15		4	Baker Bros. Advisors Lp	DIRECTOR, 10% OWNER	holding	4520.0	0	1.03	0.0	Direct	Common Stock	NEOLEUKIN THERAPEUTICS, INC.	code_ NA		44.02 (NLTX)
2023-10-03	2023-09-29	2023-09-29	4	Baker Bros. Advisors Lp	DIRECTOR	acq	1108.0	0.04	0.34	0.0	See Footnotes F1	Common Stock	IGM BIOSCIENCES, INC.	code_A code A	2896968.0	32.87 (IGMS)
2023-10-03	2023-09-29		4	Baker Bros. Advisors Lp	DIRECTOR, 10% OWNER	holding	559963.0	0	24.99	0.0	Direct	Common Stock	INCYTE CORP	code_ NA		224.09 (INCY)
2023-10-03	2023-09-29	2023-09-29	4	Baker Bros. Advisors Lp	DIRECTOR, 10% OWNER	acq	1020.0	0.0	0.05	0.0	See Footnotes F4	Common Stock	INCYTE CORP	code_A code A	33446882.0	224.09 (INCY)
2023-10-03	2023-09-29		4	Baker Bros. Advisors Lp	DIRECTOR, 10% OWNER	holding	33410.0	0	1.49	0.0	See Footnotes F3	Common Stock	INCYTE CORP	code_ NA		224.09 (INCY)
2023-10-10	2023-10-05	2023-10-05	4	Baker Bros. Advisors Lp	DIRECTOR, 10% OWNER	acq	592650.0	35.74	134.63	0.0	See Footnotes F2	Common Stock	NEOLEUKIN THERAPEUTICS, INC.	code_X code X	1658190.0	44.02 (NLTX)
2023-10-10	2023-10-05		4	Baker Bros. Advisors Lp	DIRECTOR, 10% OWNER	holding	904.0	0	0.21	0.0	Direct	Common Stock	NEOLEUKIN THERAPEUTICS, INC.	code_ NA		44.02 (NLTX)
2023-06-20	2023-06-15		3	Baker Bros. Advisors Lp	DIRECTOR	holding	148821.0	0	81.37	0.0	See Footnotes F1	Common Stock	MADRIGAL PHARMACEUTICALS, INC.	code_ NA		18.29 (MDGL)
2023-06-20	2023-06-15		3	Baker Bros. Advisors Lp	DIRECTOR	holding	1396292.0	0	763.45	0.0	See Footnotes F2	Common Stock	MADRIGAL PHARMACEUTICALS, INC.	code_ NA		18.29 (MDGL)
2023-06-20	2023-06-15	2023-06-15	4	Baker Bros. Advisors Lp	DIRECTOR, 10% OWNER	acq	51688.0	55.33	0.38	0.0	See Footnotes F1	Ordinary Shares	BEIGENE, LTD.	code_A code A	93417.0	1362.65 (BGNE)
2023-06-20	2023-06-15		4	Baker Bros. Advisors Lp	DIRECTOR, 10% OWNER	holding	2.0	0		0.0	Direct	Ordinary Shares	BEIGENE, LTD.	code_ NA		1362.65 (BGNE)

Derivative Transactions

Tips: type "code_m" to show transactions with code "M".

Filing Date	Transaction Date	Operation Date	Original Filing	Reporter	Relation	Opr	Amount^a	%(Owned)^b	‱(SO)^c	Avg Prc^d	Account	Type	Full Name	Code	Remain	Shares Outstanding (Million)^e
2023-05-24	2023-05-22	2023-05-22	4	Baker Bros. Advisors Lp	DIRECTOR, 10% OWNER	acq	10625036.0	100.0	2215.63	5.75	See Footnotes F4	Warrants To Purchase Common Stock	PRELUDE THERAPEUTICS INC	code_A code A	10625036.0	47.96 (PRLD)
2023-05-24	2023-05-22	2023-05-22	4	Baker Bros. Advisors Lp	DIRECTOR, 10% OWNER	acq	970220.0	100.0	202.32	5.75	See Footnotes F3	Warrants To Purchase Common Stock	PRELUDE THERAPEUTICS INC	code_A code A	970220.0	47.96 (PRLD)
2023-05-24	2023-05-22	2023-05-22	4	Baker Bros. Advisors Lp	DIRECTOR, 10% OWNER	acq	121178.0	19.21	25.27	5.75	See Footnotes F3	Prelude Non Voting Common Stock	PRELUDE THERAPEUTICS INC	code_A code A	630658.0	47.96 (PRLD)
2023-05-24	2023-05-22	2023-05-22	4	Baker Bros. Advisors Lp	DIRECTOR, 10% OWNER	acq	1327044.0	20.29	276.73	5.75	See Footnotes F4	Prelude Non Voting Common Stock	PRELUDE THERAPEUTICS INC	code_A code A	6539415.0	47.96 (PRLD)
2023-05-24	2023-05-22	2023-05-23	4	Baker Bros. Advisors Lp	DIRECTOR, 10% OWNER	dsp	12500.0	100.0	0.77	17.01	See Footnotes F5	Non Qualified Stock Options (Right To Buy)	ACADIA PHARMACEUTICALS INC	code_M code M	0.0	162.63 (ACAD)
2023-05-24	2023-05-22	2023-05-23	4	Baker Bros. Advisors Lp	DIRECTOR, 10% OWNER	dsp	12500.0	100.0	0.77	17.01	See Footnotes F4	Non Qualified Stock Options (Right To Buy)	ACADIA PHARMACEUTICALS INC	code_M code M	0.0	162.63 (ACAD)
2023-06-02	2023-06-01	2023-06-01	4	Baker Bros. Advisors Lp	DIRECTOR	acq	37500000.0	100		2.0	See Footnotes F4	Warrants To Purchase Common Stock	TSCAN THERAPEUTICS, INC.	code_A code A	34307290.0	19.48 (TCRX)
2023-06-05	2023-06-01	2023-06-01	4	Baker Bros. Advisors Lp	DIRECTOR, 10% OWNER	dsp	22090.0	50.0	1.36	23.9	See Footnotes F4	Non Qualified Stock Options (Right To Buy)	ACADIA PHARMACEUTICALS INC	code_A code A	22090.0	162.63 (ACAD)
2023-06-08	2023-06-06	2023-06-06	4	Baker Bros. Advisors Lp	DIRECTOR	acq	52472.0	100.0	15.0	15.19	See Footnotes F5	Non Qualified Share Option (Right To Buy)	KINIKSA PHARMACEUTICALS, LTD.	code_A code A	52472.0	34.97 (KNSA)
2023-06-08	2023-06-06	2023-06-06	4	Baker Bros. Advisors Lp	DIRECTOR	acq	52472.0	100.0	15.0	15.19	See Footnotes F4	Non Qualified Share Option (Right To Buy)	KINIKSA PHARMACEUTICALS, LTD.	code_A code A	52472.0	34.97 (KNSA)
2023-06-12	2023-06-08	2023-06-08	4	Baker Bros. Advisors Lp	DIRECTOR	acq	50000.0	100	11.67	0.79	See Footnotes F1	Non Qualified Stock Option (Right To Buy)	NEOLEUKIN THERAPEUTICS, INC.	code_A code A	25000.0	42.83 (NLTX)
2023-06-13	2023-06-09	2023-06-09	4	Baker Bros. Advisors Lp	DIRECTOR, 10% OWNER	acq	47370.0	100	8.35	0.5	See Footnotes F1	Non Qualified Stock Option (Right To Buy)	TALIS BIOMEDICAL CORP	code_A code A	23685.0	56.74 (TLIS)
2023-06-15	2023-06-13	2023-06-13	4	Baker Bros. Advisors Lp	DIRECTOR	acq	70000.0	100	35.93	2.66	See Footnotes F1	Non Qualified Stock Option (Right To Buy)	TSCAN THERAPEUTICS, INC.	code_A code A	35000.0	19.48 (TCRX)
2023-06-16	2023-06-14	2023-06-14	4	Baker Bros. Advisors Lp	DIRECTOR, 10% OWNER	acq	11294.0	100.0	0.51	61.44	See Footnotes F5	Non Qualified Stock Option (Right To Buy)	INCYTE CORP	code_A code A	11294.0	223.09 (INCY)
2023-06-16	2023-06-14	2023-06-14	4	Baker Bros. Advisors Lp	DIRECTOR, 10% OWNER	acq	11294.0	100.0	0.51	61.44	See Footnotes F6	Non Qualified Stock Option (Right To Buy)	INCYTE CORP	code_A code A	11294.0	223.09 (INCY)
2023-06-21	2023-06-16	2023-06-16	4	Baker Bros. Advisors Lp	DIRECTOR, 10% OWNER	acq	47000.0	100	9.8	5.56	See Footnotes F1	Non Qualified Stock Option (Right To Buy)	PRELUDE THERAPEUTICS INC	code_A code A	23500.0	47.96 (PRLD)
2023-06-28	2023-06-26	2023-06-26	4	Baker Bros. Advisors Lp	DIRECTOR	acq	5625000.0	56.9	1906.26	8.0	See Footnotes F2	Non Voting Common Stock	IGM BIOSCIENCES, INC.	code_P code P	9886217.0	29.51 (IGMS)
2023-07-05	2023-06-30	2023-06-30	4	Baker Bros. Advisors Lp	DIRECTOR, 10% OWNER	acq	80000.0	100	15.28	6.9	See Footnotes F1	Non Qualified Stock Options (Right To Buy)	KODIAK SCIENCES INC.	code_A code A	40000.0	52.36 (KOD)
2023-10-05	2023-10-03	2023-10-03	4	Baker Bros. Advisors Lp	DIRECTOR	acq	1648098.0	100	892.25	151.69	See Footnotes F3	Common Stock Warrant (Right To Buy)	MADRIGAL PHARMACEUTICALS, INC.	code_P code P	1522651.0	18.47 (MDGL)
2023-10-10	2023-10-05	2023-10-05	4	Baker Bros. Advisors Lp	DIRECTOR, 10% OWNER	dsp	592650.0	28.04	134.63	0.0	See Footnotes F2	Pre Funded Warrants	NEOLEUKIN THERAPEUTICS, INC.	code_X code X	1521176.0	44.02 (NLTX)
2023-06-20	2023-06-15		3	Baker Bros. Advisors Lp	DIRECTOR	holding	360750.0	0	197.25	0.0	See Footnotes F2	Series B Convertible Preferred Stock	MADRIGAL PHARMACEUTICALS, INC.	code_ NA		18.29 (MDGL)
2023-06-20	2023-06-15		3	Baker Bros. Advisors Lp	DIRECTOR	holding	39250.0	0	21.46	0.0	See Footnotes F1	Series B Convertible Preferred Stock	MADRIGAL PHARMACEUTICALS, INC.	code_ NA		18.29 (MDGL)
2023-06-20	2023-06-15		3	Baker Bros. Advisors Lp	DIRECTOR	holding	200378.0	0	109.56	0.0	See Footnotes F1	Series A Convertible Preferred Stock	MADRIGAL PHARMACEUTICALS, INC.	code_ NA		18.29 (MDGL)
2023-06-20	2023-06-15		3	Baker Bros. Advisors Lp	DIRECTOR	holding	1769419.0	0	967.47	0.0	See Footnotes F2	Series A Convertible Preferred Stock	MADRIGAL PHARMACEUTICALS, INC.	code_ NA		18.29 (MDGL)
2023-06-20	2023-06-15	2023-06-15	4	Baker Bros. Advisors Lp	DIRECTOR, 10% OWNER	acq	107900.0	100	0.79	16.41	See Footnotes F1	Share Option (Right To Buy)	BEIGENE, LTD.	code_A code A	53950.0	1362.65 (BGNE)
2023-11-24	2023-11-22	2023-11-22	4	Baker Bros. Advisors Lp	10% OWNER	dsp	2116349.0	12.96	2178.0	0.0	See Footnotes F3	Warrants (Right To Buy)	BELLICUM PHARMACEUTICALS, INC	code_X code X	14217844.0	9.72 (BLCM)
2023-12-13	2023-12-13	2023-12-13	4	Baker Bros. Advisors Lp	DIRECTOR, 10% OWNER	acq	7936759.0	44.17	1447.63	3.15	See Footnotes F3	Warrants To Purchase Common Stock	PRELUDE THERAPEUTICS INC	code_A code A	17968343.0	54.83 (PRLD)
2023-12-18	2023-12-14	2023-12-14	4	Baker Bros. Advisors Lp	FORMER 10% OWNER	dsp	63337.0	100.0	3.36	65.9	See Footnotes F8	Stock Options (Right To Buy)	SEAGEN INC.	code_D code D	0.0	188.66 (SGEN)
2023-12-20	2023-12-18	2023-12-18	4	Baker Bros. Advisors Lp	FORMER 10% OWNER	acq	2877250.0	100	3061.59	0.0	See Footnotes F1	Prefunded Warrants	NEUROGENE INC.	code_A code A	2656101.0	9.4 (NGNE)
2023-12-20	2023-12-18		4	Baker Bros. Advisors Lp	FORMER 10% OWNER	holding	425987.0	0	453.28	0.0	See Footnotes F1	Prefunded Warrants	NEUROGENE INC.	code_ NA		9.4 (NGNE)

^a Sum of same type of securities in the form
^b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
^c Relative to issuer's shares outstanding (1/10000)
^d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
^e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)